LINEAGE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Lineage, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead the Lineage Class Action Lawsuit LINE
SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces that purchasers of…
NYSE Content Advisory: Pre-market update + Ambiq raises $96 million in IPO
NEW YORK, July 30, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE Content Advisory: Pre-market update + Accelerant celebrates IPO
NEW YORK, July 25, 2025 /PRNewswire/ -- The New York Stock Exchange…
Via announces confidential submission of draft registration statement related to proposed public offering
NEW YORK, July 16, 2025 /PRNewswire/ -- Via Transportation, Inc. today announced…
Berlin Heals Announces Publication of Two-Year Clinical Outcomes of Cardiac Microcurrent Therapy in ESC Heart Failure
Study shows sustained improvements in heart failure symptoms and function following long-term C-MIC…
Soluna Holdings, Inc. Announces Pricing of $5 Million Public Offering
ALBANY, N.Y.--(BUSINESS WIRE)--$SLNH #SLNH--Soluna Holdings, Inc. (“Soluna” or the “Company”) (NASDAQ: SLNH),…
VivoPower Commences $29 Million Shareholder Loan Financing Retirement Plan
LONDON, July 07, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (Nasdaq: VVPR)…
2025 Kia Telluride ranks number one in its segment in J.D. Power 2025 U.S. Initial Quality Study (IQS)
Kia’s Award-Winning Three-Row SUV Earns Top Spot in Upper Midsize SUV Segment2025…
Hyundai Motor Group Tops 2025 J.D. Power U.S. Initial Quality Study
Hyundai Motor Group ranks No.1 among all corporations in the J.D. Power…
Instil Bio Announces U.S. F.D.A. Clearance of Investigational New Drug (IND) Application for AXN-2510, a PD-L1xVEGF Bispecific Antibody, for a Phase 1 Trial in Relapsed/Refractory Solid Tumors
July 02, 2025 06:00 ET | Source: Instil Bio US phase 1…